197 related articles for article (PubMed ID: 25263934)
1. Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease.
Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
J Crohns Colitis; 2014 Dec; 8(12):1723-9. PubMed ID: 25263934
[TBL] [Abstract][Full Text] [Related]
2. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
[TBL] [Abstract][Full Text] [Related]
4. May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel disease.
Linn AJ; van Dijk L; Smit EG; Jansen J; van Weert JC
J Crohns Colitis; 2013 Dec; 7(11):e543-50. PubMed ID: 23660489
[TBL] [Abstract][Full Text] [Related]
5. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
6. Predictors of medication adherence in inflammatory bowel disease.
Ediger JP; Walker JR; Graff L; Lix L; Clara I; Rawsthorne P; Rogala L; Miller N; McPhail C; Deering K; Bernstein CN
Am J Gastroenterol; 2007 Jul; 102(7):1417-26. PubMed ID: 17437505
[TBL] [Abstract][Full Text] [Related]
7. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
Campos S; Portela F; Sousa P; Sofia C
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
[TBL] [Abstract][Full Text] [Related]
9. Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease.
Gallinger ZR; Rumman A; Nguyen GC
J Crohns Colitis; 2016 Aug; 10(8):892-7. PubMed ID: 26896087
[TBL] [Abstract][Full Text] [Related]
10. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
[TBL] [Abstract][Full Text] [Related]
11. Patients' beliefs and attitudes about their treatment for inflammatory bowel disease in Korea.
Kim SB; Kim KO; Jang BI; Kim ES; Cho KB; Park KS; Chung MK; Jeon SW;
J Gastroenterol Hepatol; 2016 Mar; 31(3):575-80. PubMed ID: 26313162
[TBL] [Abstract][Full Text] [Related]
12. Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases.
Almakadma AH; De Vol A; Alabdaljabar MS; Aldosari S; Muhsen I; AlFreihi O; Kurdi A; Almadi M; Alsohaibani F
Saudi J Gastroenterol; 2023; 29(4):233-239. PubMed ID: 37282444
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease.
Selinger CP; Robinson A; Leong RW
Expert Opin Drug Saf; 2011 Nov; 10(6):863-70. PubMed ID: 21548837
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective.
Grunert PC; Reuken PA; Stallhofer J; Teich N; Stallmach A
J Crohns Colitis; 2020 Dec; 14(12):1702-1708. PubMed ID: 32564068
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey.
Nahon S; Lahmek P; Saas C; Durance C; Olympie A; Lesgourgues B; Gendre JP
Inflamm Bowel Dis; 2011 Jun; 17(6):1270-6. PubMed ID: 21560190
[TBL] [Abstract][Full Text] [Related]
16. Use of Complementary and Alternative Medicine in Inflammatory Bowel Disease Around the World.
Zezos P; Nguyen GC
Gastroenterol Clin North Am; 2017 Dec; 46(4):679-688. PubMed ID: 29173516
[TBL] [Abstract][Full Text] [Related]
17. The role of complementary medicine in European and Asian patients with inflammatory bowel disease.
Moody GA; Eaden JA; Bhakta P; Sher K; Mayberry JF
Public Health; 1998 Jul; 112(4):269-71. PubMed ID: 9724953
[TBL] [Abstract][Full Text] [Related]
18. Adherence to medical treatment in inflammatory bowel disease patients.
Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease.
Goodhand JR; Kamperidis N; Sirwan B; Macken L; Tshuma N; Koodun Y; Chowdhury FA; Croft NM; Direkze N; Langmead L; Irving PM; Rampton DS; Lindsay JO
Aliment Pharmacol Ther; 2013 Nov; 38(9):1097-108. PubMed ID: 24099471
[TBL] [Abstract][Full Text] [Related]
20. Practices and attitudes toward complementary and alternative medicine in inflammatory bowel disease: a survey of gastroenterologists.
Gallinger ZR; Nguyen GC
J Complement Integr Med; 2014 Dec; 11(4):297-303. PubMed ID: 25294717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
